Background Physiological changes in pregnancy may result in significant alterations in
endocrine hormone profiles, serum and urine electrolytes and endocrine gland morphology …

Objective: The aim was to formulate clinical practice guidelines for acromegaly. Participants:
The Task Force included a chair selected by the Endocrine Society Clinical Guidelines …

Background In 2007, we published an opinion document to review the role of pegvisomant
(PEG) in the treatment of acromegaly. Since then, new evidence emerged on the …

Pregnancies are rare in women with pituitary adenomas, which may relate to hormone
excess from secretory subtypes such as prolactinomas or corticotroph adenomas …

Pituitary adenomas can affect fertility and pregnancy outcomes, if pregnancy does ensue,
because of oversecretion of hormones as well as by causing hypopituitarism. In addition, the …

Although fertility is frequently impaired in women with acromegaly, pregnancy is apparently
becoming more common due to improvement in acromegaly treatment as well as in fertility …

Interpretation of laboratory investigations relies on reference intervals. Physiological
changes in pregnancy may result in significant changes in normal values for many …

To summarize all available data on pregnancy outcome of acromegaly patients exposed to
the growth hormone receptor antagonist pegvisomant (PEGV) during pregnancy as present …

Introduction Acromegaly is a rare disorder in which, due to the high incidence of secondary
hypogonadism, pregnancies are relatively rare. However, some women with acromegaly do …

Objective To assess the outcome of pregnancies in a large cohort of women with
acromegaly. Design and methods This is a retrospective analysis of 31 pregnancies in 20 …